OBJECTIVE: We used data from a routine HIV testing program to develop risk scores to identify patients with undiagnosed HIV infection while reducing the number of total tests performed. DESIGN: Multivariate logistic regression. METHODS: We included demographic factors from HIV testing data collected in 134 Botswana Ministry of Health & Wellness facilities during two periods (1 October 2018- 19 August 2019 and 1 December 2019 to 30 March 2020). In period 2, the program collected additional demographic and risk factors. We randomly split each period into prediction/validation datasets and used multivariate logistic regression to identify factors associated with positivity; factors with adjusted odds ratios at least 1.5 were included in the risk score with weights equal to their coefficient. We applied a range of risk score cutoffs to validation datasets to determine tests averted, test positivity, positives missed, and costs averted. RESULTS: In period 1, three factors were significantly associated with HIV positivity (coefficients range 0.44-0.87). In period 2, 12 such factors were identified (coefficients range 0.44-1.37). In period 1, application of risk score cutoff at least 1.0 would result in 50% fewer tests performed and capture 61% of positives. In period 2, a cutoff at least 1.0 would result in 13% fewer tests and capture 96% of positives; a cutoff at least 2.0 would result in 40% fewer tests and capture 83% of positives. Costs averted ranged from 12.1 to 52.3%. CONCLUSION: Botswana's testing program could decrease testing volume but may delay diagnosis of some positive patients. Whether this trade-off is worthwhile depends on operational considerations, impact of testing volume on program costs, and implications of delayed diagnoses.
OBJECTIVE: We used data from a routine HIV testing program to develop risk scores to identify patients with undiagnosed HIV infection while reducing the number of total tests performed. DESIGN: Multivariate logistic regression. METHODS: We included demographic factors from HIV testing data collected in 134 Botswana Ministry of Health & Wellness facilities during two periods (1 October 2018- 19 August 2019 and 1 December 2019 to 30 March 2020). In period 2, the program collected additional demographic and risk factors. We randomly split each period into prediction/validation datasets and used multivariate logistic regression to identify factors associated with positivity; factors with adjusted odds ratios at least 1.5 were included in the risk score with weights equal to their coefficient. We applied a range of risk score cutoffs to validation datasets to determine tests averted, test positivity, positives missed, and costs averted. RESULTS: In period 1, three factors were significantly associated with HIV positivity (coefficients range 0.44-0.87). In period 2, 12 such factors were identified (coefficients range 0.44-1.37). In period 1, application of risk score cutoff at least 1.0 would result in 50% fewer tests performed and capture 61% of positives. In period 2, a cutoff at least 1.0 would result in 13% fewer tests and capture 96% of positives; a cutoff at least 2.0 would result in 40% fewer tests and capture 83% of positives. Costs averted ranged from 12.1 to 52.3%. CONCLUSION: Botswana's testing program could decrease testing volume but may delay diagnosis of some positive patients. Whether this trade-off is worthwhile depends on operational considerations, impact of testing volume on program costs, and implications of delayed diagnoses.
Authors: Jillian Pintye; Alison L Drake; John Kinuthia; Jennifer A Unger; Daniel Matemo; Renee A Heffron; Ruanne V Barnabas; Pamela Kohler; R Scott McClelland; Grace John-Stewart Journal: Clin Infect Dis Date: 2017-03-15 Impact factor: 9.079
Authors: Susan Regan; Elena Losina; Senica Chetty; Janet Giddy; Rochelle P Walensky; Douglas Ross; Helga Holst; Jeffrey N Katz; Kenneth A Freedberg; Ingrid V Bassett Journal: PLoS One Date: 2013-04-23 Impact factor: 3.240
Authors: Vlad Novitsky; Hermann Bussmann; Lillian Okui; Andrew Logan; Sikhulile Moyo; Erik van Widenfelt; Mompati Mmalane; Quanhong Lei; Molly P Holme; Joseph Makhema; Shahin Lockman; Victor Degruttola; M Essex Journal: J Int AIDS Soc Date: 2015-05-29 Impact factor: 5.396
Authors: Jennifer E Balkus; Elizabeth Brown; Thesla Palanee; Gonasagrie Nair; Zakir Gafoor; Jingyang Zhang; Barbra A Richardson; Zvavahera M Chirenje; Jeanne M Marrazzo; Jared M Baeten Journal: J Acquir Immune Defic Syndr Date: 2016-07-01 Impact factor: 3.731
Authors: J Todd; I Cremin; N McGrath; J-B Bwanika; A Wringe; M Marston; I Kasamba; P Mushati; T Lutalo; V Hosegood; B Zaba Journal: Sex Transm Infect Date: 2009-04 Impact factor: 3.519